Transaction · 0001231919-26-000457

Ra Capital Management, L.P.

RA CAPITAL MANAGEMENT, L.P., DIR, reported an open-market or private purchase at Hemab Therapeutics Holdings, Inc. involving 133750.000000 shares for an estimated $2407500.00. Reported holdings after the transaction were 354938.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PDIR
COAGHemab Therapeutics Holdings, Inc.
Trade date
May 04, 2026
Filing date
May 06, 2026
View on SEC Insider profile
Estimated value$2.40MShares × reported price
Shares traded133k$18.00 per share
Holdings after354kIndirect · See footnotes
% of reported position traded60.47%This security and ownership context
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 221,188 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

COAG price since this filing

Daily closing prices, with the filing date and available return windows
COAG · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001231919-26-000457
Common Stock
Transaction date
May 04, 2026
Filed May 06, 2026, 11:16 PM · 2d delay
Shares
133,750 sh
$18.00 per share
Estimated value
$2.40M
Computed from shares × price
Holdings after
354,938 sh
Indirect · See footnotes

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Buy Director Buy Large Buy Large Holdings Increase Repeat Buyer 10% Owner Buy
Filing-only score

+62 points

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • director_buy+6 points

    is_director = true

    Director open-market purchase.
  • cluster_buy+14 points

    cluster-buy signal matched

    Multiple insiders bought within the configured window.
  • repeat_buyer+8 points

    repeat-buyer signal matched

    Same insider bought again within the configured window.
  • large_buy_absolute+10 points

    large-buy signal with absolute_triggered = true

    Open-market purchase exceeds the configured absolute threshold.
  • large_holdings_increase+8 points

    large-holdings-increase signal matched

    Reported acquired shares meet the configured percentage of post-transaction holdings.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initi…

  2. F2

    RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus II Fund, L.P. (the "Nexus Fund II") and RA Capital Nexus IV Fu…

  3. F3

    Held directly by the Fund.

  4. F4

    Held directly by Nexus Fund II.

  5. F5

    Held directly by Nexus Fund IV.

  6. F6

    The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.00 to $24.9994 inclusive. The Reporting Persons undertake to…

  7. F7

    The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.495 to $24.455 inclusive. The Reporting Persons undertake to…

  8. F8

    The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.505 to $25.00 inclusive. The Reporting Persons undertake to…

Original filing · 0001231919-26-000457
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

COAG